Primary tumor surgery: Large bowel resection.
Primary tumor surgery (bowel resection) combined with prophylactic cholecystectomy: Large bowel resection combined and cholecystectomy.
The investigators want to study the effectiveness of prophylactic cholecystectomy in patients with midgut neuroendocrine tumor (jejunum, ileum or proximal colon) who require primary tumor surgery. When patients are diagnosed and are tributary to surgical treatment, the tumor might compromise vascularization, and patients need an extensive bowel resection. The patients might also receive medical treatment with somatostatin analogs. The combination of extensive bowel resection and medical treatment might increase gallbladder stones, but patients might not develop biliary stone disease, as in the general population, where 20% of the population have gallbladder stones but only a 10 to 15 % of the population will develop symptoms.
The idea comes from the lack of literature about the incidence of biliary Stone disease in patients with midgut NET tumors.
It's a multicentric, open-label and randomized clinical trial to evaluate the incidence of biliary stone disease in patients with midgut NET who require primary tumor surgery combined or not to cholecystectomy.
Our hypothesis suggests that patients with midgut neuroendocrine tumor who require primary tumor resection without the combination of prophylactic cholecystectomy do not have an increased incidence of biliary stone disease two years after the surgery, regardless of treatment with SSA.
| Facility | City | Region | Status |
|---|---|---|---|
| Hospital Universitari Trias i Pujol | Badalona | Barcelona | Not Yet Recruiting |
| IDIBELL, Hospital Universitari de Bellvitge. | Barcelona | Barcelona | Recruiting |
| Hospital del Mar | Barcelona | Barcelona | Not Yet Recruiting |
| Hospital Universitari Vall d'Hebron | Barcelona | Barcelona | Not Yet Recruiting |
| Instituto Catalán de Oncología | L'Hospitalet de Llobregat | Barcelona | Active Not Recruiting |
| Hospital Universitario Gregorio Marañón | Madrid | Madrid | Not Yet Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04735198 on ClinicalTrials.gov ↗ ← All trials in Spain